Lunar reports higher sales, profits

Article

Lunar continues to post improvingfinancial numbers. The Madison, WI, company last month reportedsharply higher results for the third quarter of 1994 (end-March). Total revenues for the quarter increased 21%, to $8 millionfrom $6.6 million in the same

Lunar continues to post improvingfinancial numbers. The Madison, WI, company last month reportedsharply higher results for the third quarter of 1994 (end-March).

Total revenues for the quarter increased 21%, to $8 millionfrom $6.6 million in the same period the year before. Net incomefor the quarter jumped 73%, to $2 million compared to $1.2 millionin the second quarter of 1993. The jump in Lunar's financial resultsis due to strong sales of its Achilles line, according to thecompany.

While Achilles is surging, Lunar reported that it has experienceddelays in finalizing the system integration of hardware and softwarefor its Expert high-end bone densitometry system. While severalbeta sites have been successfully installed, the company doesnot expect extensive shipments of Expert during the current fiscalyear.

Lunar is also the exclusive North American distributor forEsaote Biomedica's Artoscan niche MRI system.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.